RT Journal T1 Application progress of thrombolysis in retinal artery occlusionYANG Ming Overview WEI Wenbin Guidance Beijing Tongren Hospital, Capital Medical University / Beijing Tongren Eye Center / Beijing key Laboratory of Intraocular Tumor Diagnosis and Treatment / Beijing Ophthalmology&Visual Sciences Key Lab / Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing 100730, ChinaAbstract: A1 Central retinal artery occlusion(CRAO)is the most common cause of acute vision loss. Thrombolysis is a more radical treatment than conservative treatment, including arterial thrombolysis and intravenous thrombolysis, as well as the combination therapy of thrombolysis and other therapies. Thrombolysis treatment can improve the visual acuity of CRAO patients, but because of its lack of randomized controlled trials, further clinical studies are needed to determine their efficacy and safety. Our review summarized the application progress of thrombolysis in recent ten years, further evaluated its safety and effectiveness, and provided an evidence for clinical application. PB Journal of Otolaryngology and Ophthalmology of Shandong University FD 2020-07-20 YR 2020 JF Journal of Otolaryngology and Ophthalmology of Shandong University JO Journal of Otolaryngology and Ophthalmology of Shandong University VO 34 IS 4 SP 5 DO 10.6040/j.issn.1673-3770.1.2020.048 K1 Thrombolysis;Retinal artery occlusion/therapy;Arterial thrombolysis;Intravenous thrombolysis LK {http://ebhyxbwk.njournal.sdu.edu.cn/EN/article/article_2716.shtml}